Form 144 - Report of proposed sale of securities:
SEC Accession No. 0001972481-25-000242
Filing Date
2025-10-07
Accepted
2025-10-07 16:26:41
Documents
1

Document Format Files

Seq Description Document Type Size
1 primary_doc.html 144  
1 primary_doc.xml 144 8833
  Complete submission text file 0001972481-25-000242.txt   10292
Mailing Address 195 CHURCH STREET 16TH FLOOR NEW HAVEN CT 06510
Business Address 195 CHURCH STREET 16TH FLOOR NEW HAVEN CT 06510 203-304-2499
Trevi Therapeutics, Inc. (Subject) CIK: 0001563880 (see all company filings)

EIN.: 450834299 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 144 | Act: 33 | File No.: 001-38886 | Film No.: 251380143
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address C/O TREVI THERAPEUTICS, INC. 195 CHURCH STREET, FL. 16 NEW HAVEN CT 06510
Business Address
Delfini Lisa (Reporting) CIK: 0001873253 (see all company filings)

Type: 144